Stocksigma LogoStocksigma Logo

Amanta Healthcare Reports Q2FY27 IPO Proceeds Utilization and Capex Delays

CRISIL Ratings issued the Monitoring Agency Report for Amanta Healthcare for the quarter ended 30th Sep'26 regarding its Rs 12,600 lakh IPO proceeds

Amanta Healthcare Reports Q2FY27 IPO Proceeds Utilization and Capex Delays

Amanta Healthcare Ltd 路 Others (Uncategorized) 路 04 Nov 2026, 7:23 pm

Amanta Healthcare Reports Q2FY27 IPO Proceeds Utilization and Capex Delays CRISIL Ratings issued the Monitoring Agency Report for Amanta Healthcare for the quarter ended 30th Sep'26 regarding its Rs 12,600 lakh IPO proceeds. Total utilization reached Rs 10,082.69 lakh, leaving Rs 2,517.31 lakh unutilized, primarily deployed in bank fixed deposits. Net capex deployment across SteriPort and SVP manufacturing lines stood at Rs 7,495.43 lakh versus the original Rs 8,000 lakh FY26 estimate, reflecting project implementation delays due to supplier terms finalization and delayed work completion. No deviation was reported in issue objects.

Original exchange filing (PDF)

More announcements from Amanta Healthcare Ltd

All Amanta Healthcare Ltd announcements